Table 7 Treatment indications for bone sparing medication in the SALT Osteoporosis Study

Lumbar fracture on IVA with a vertebral height reduction ≥20%^a

Thoracic fracture on IVA with a vertebral height reduction ≥25%^a

Fracture risk according to FRAX ≥age specific threshold (see Table 6) and

DXA (hip and/or spine) T-score ≤ −2

Treatment indication according to the actual Dutch guideline for GP’s for primary osteoporosis (see Table 1)